Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Multivalent Small-Molecule Pan-RAS Inhibitors.

Welsch ME, Kaplan A, Chambers JM, Stokes ME, Bos PH, Zask A, Zhang Y, Sanchez-Martin M, Badgley MA, Huang CS, Tran TH, Akkiraju H, Brown LM, Nandakumar R, Cremers S, Yang WS, Tong L, Olive KP, Ferrando A, Stockwell BR.

Cell. 2017 Feb 23;168(5):878-889.e29. doi: 10.1016/j.cell.2017.02.006.

PMID:
28235199
2.

Towards personalized agriculture: what chemical genomics can bring to plant biotechnology.

Stokes ME, McCourt P.

Front Plant Sci. 2014 Jul 11;5:344. doi: 10.3389/fpls.2014.00344. eCollection 2014.

3.

Detection of parasitic plant suicide germination compounds using a high-throughput Arabidopsis HTL/KAI2 strigolactone perception system.

Toh S, Holbrook-Smith D, Stokes ME, Tsuchiya Y, McCourt P.

Chem Biol. 2014 Aug 14;21(8):988-98. doi: 10.1016/j.chembiol.2014.07.005. Epub 2014 Aug 7. Erratum in: Chem Biol. 2014 Sep 18;21(9):1253.

4.

The application of network label propagation to rank biomarkers in genome-wide Alzheimer's data.

Stokes ME, Barmada MM, Kamboh MI, Visweswaran S.

BMC Genomics. 2014 Apr 14;15:282. doi: 10.1186/1471-2164-15-282.

5.

Interplay between sucrose and folate modulates auxin signaling in Arabidopsis.

Stokes ME, Chattopadhyay A, Wilkins O, Nambara E, Campbell MM.

Plant Physiol. 2013 Jul;162(3):1552-65. doi: 10.1104/pp.113.215095. Epub 2013 May 20.

6.

Application of a spatially-weighted Relief algorithm for ranking genetic predictors of disease.

Stokes ME, Visweswaran S.

BioData Min. 2012 Dec 3;5(1):20. doi: 10.1186/1756-0381-5-20.

7.

Lifetime economic burden of prostate cancer.

Stokes ME, Ishak J, Proskorovsky I, Black LK, Huang Y.

BMC Health Serv Res. 2011 Dec 28;11:349. doi: 10.1186/1472-6963-11-349.

8.

Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients.

Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Rupnow MF, Hammond J.

BMC Health Serv Res. 2011 May 31;11:135. doi: 10.1186/1472-6963-11-135.

9.

Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.

Stokes ME, Black L, Benedict A, Roehrborn CG, Albertsen P.

Prostate Cancer Prostatic Dis. 2010 Sep;13(3):278-84. doi: 10.1038/pcan.2010.5. Epub 2010 Mar 9.

PMID:
20212521
10.

Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.

Fourcade RO, Benedict A, Black LK, Stokes ME, Alcaraz A, Castro R.

BJU Int. 2010 Jan;105(1):49-56. doi: 10.1111/j.1464-410X.2009.08716.x.

11.

Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.

Stokes ME, Muehlenbein CE, Marciniak MD, Faries DE, Motabar S, Gillespie TW, Lipscomb J, Knopf KB, Buesching DP.

J Manag Care Pharm. 2009 Oct;15(8):669-82.

12.

First-year costs of treating prostate cancer: estimates from SEER-Medicare data.

Roehrborn CG, Albertsen P, Stokes ME, Black L, Benedict A.

Prostate Cancer Prostatic Dis. 2009;12(4):355-60. doi: 10.1038/pcan.2009.21. Epub 2009 May 26.

PMID:
19468284
13.

Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.

Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC.

Value Health. 2008 Mar-Apr;11(2):213-20. doi: 10.1111/j.1524-4733.2007.00226.x.

14.
15.
16.

Biostatistical implications of design, sampling, and measurement to health science data analysis.

Koch GG, Gillings DB, Stokes ME.

Annu Rev Public Health. 1980;1:163-225. Review. No abstract available.

PMID:
6753862

Supplemental Content

Loading ...
Support Center